Gapping up
In reaction to earnings/guidance:
- VOXX +58.1%, MATX +6.6% (guides Q4 EPS above consensus), LMNX +5.7%, GNMK +5.3% (issues upside Q4 rev guidance), ACI +4.2%, CNXC +3%, BDX +2.7%, LE +2.7%, SHAK +2.2%, ACIA +1.6% (issues upside Q4 EPS guidance, inline rev guidance; also files counterclaim against CSCO), SNX +1.5% (also reinstates dividend), EAR +1.3% (guides Q4 revs above consensus), CTRN +1%
Other news:
- LJPC +48.5% (announces exclusive licensing agreement for GIAPREZA (Angiotensin II) and XERAVA (Eravacycline) in Europe)
- TTOO +39.4% (says its T2SARS-CoV-2 Panel is capable of detecting multiple variants)
- FTFT +13.9% (bounces after big drop on Monday; WMT's creation of new fintech startup seen as possible catalyst)
- BGNE +10% (BGNE announces a collaboration with NVS)
- QTRX +6.9% (receives FDA EAU for Simoa SARS-CoV-2 N Protein Antigen Test)
- AMRX +6.7% (will acquire a 98% interest in Kashiv Specialty Pharmaceuticals)
- RCUS +6% (to present preliminary ARC-8 data at ASCO)
- USAS +5.1% (declares commercial production at Relief Canyon)
- HEC +5.1% (Online therapy company Talkspace is rumored to be nearing a deal to go public through a SPAC merger with HEC, according to Bloomberg)
- EYPT +4.5% (provides clinical update and product revenue guidance)
- XPEV +3.6% (secures RMB12.8 bln credit line)
- CLSD +3.3% (announces that the first patients have been enrolled in its Phase 1/2a clinical trial of CLS-AX in patients with neovascular age-related macular degeneration; expects data from first cohort of patients in mid-2021)
- PXLW +2.9% (signs new multi-year collaboration agreement with TCL)
- ANGI +2.3% (reports Dec operating metrics)
- SAGE +2.1% (BIIB discloses 10.7% stake in SAGE)
- ADPT +1.9% (ADPT announces collaboration with AZN)
- FLR +1.9% (awarded reimbursable services contract), ET +1.8% (new CFO)
- VIR +1.6% (Vir Biotechnology and GlaxoSmithKline (GSK) provide update on NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19)
- VSAT +1.6% (ViaSat and SKY Brasil announce partnership to expand the distribution and availability of Viasat's high-quality satellite internet service to more homes across Brazil)
- X +1.4% (steel cos urge Biden to maintain steel tariffs, according to Reuters)
Analyst comments:
- UPWK +4.7% (upgraded to Buy from Neutral at Citigroup)
- AFL +4.4% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- CLR +3.3% (upgraded to Neutral from Underperform at Mizuho)
- OXY +3.2% (upgraded to Buy from Neutral at Mizuho)
- DRH +2.9% (upgraded to Outperform from Mkt Perform at Raymond James)
- TSM +2.5% (upgraded to Outperform from Mkt Perform at Bernstein)
- PLUG +2.5% (initiated with a Buy at Truist)
- WFC +1.8% (upgraded to Buy from Neutral at UBS)
- MRO +1.7% (upgraded to Buy from Neutral at Mizuho)
- COP +1.6% (upgraded to Buy from Neutral at Mizuho)
- OSK +1.4% (upgraded to Outperform from Neutral at Credit Suisse)
- IFF +1.1% (upgraded to Buy from Hold at Societe Generale)